Guo Dong Xu
Keine laufenden Positionen mehr
Profil
Guo Dong Xu served as a Member-Supervisory Board at Wuhan Canvest Biotechnology Co., Ltd.
before obtaining a doctorate degree from Wuhan University.
Ehemalige bekannte Positionen von Guo Dong Xu
| Unternehmen | Position | Ende |
|---|---|---|
Wuhan Canvest Biotechnology Co., Ltd.
 Wuhan Canvest Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China. | Direktor/Vorstandsmitglied | - |
Ausbildung von Guo Dong Xu
| Wuhan University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Wuhan Canvest Biotechnology Co., Ltd.
Wuhan Canvest Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China. | Health Technology |
